DSM publishes DNA sequence of Aspergillus niger genome
Rob van Leen, Chief Innovation Officer at DSM, commented: "DSM realizes that the Aspergillus niger genome is of great interest to many other parties, both in industry and the academic world. DSM is releasing the DNA sequence to enable further research in this field. We are very pleased about this publication, which fits perfectly in our open-innovation policy. The Aspergillus niger research project is a foundation for our efforts in the area of 'white' or industrial biotechnology - and that area is an important part of the innovation boost in DSM's strategy Vision 2010 - Building on Strengths."
Aspergillus niger is a micro-organism that DSM uses for the production of enzymes and other compounds, such as citric acid. These are mainly used in foodstuffs to improve taste, shelf life, texture, nutritional value, etc. At the beginning of this century, DSM started work on the determination of the complete DNA sequence of Aspergillus niger and the identification of the functions of the different genes. The project has resulted in a high-quality genome sequence of 33.9 million base pairs with more than 14,000 unique genes. The (possible) functions of around 6500 of these genes could be established.
According to the company, the Aspergillus niger genome project has resulted in numerous patent filings by DSM and has laid the basis for a number of new DSM products. In addition, the project has resulted in a valuable scientific network.
Most read news
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.